51.80 0.00 (0.00%)After hours: 4:16PM EST, Subscribe to Premium to view Fair Value for NEO, In this article we present the list of Top 10 Healthcare Stocks To Buy for the Future. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. The company generates revenue from Clinical Services.See more from Benzinga * Click here for options trades from Benzinga * Earnings Scheduled For October 27, 2020 * Stocks That Hit 52-Week Highs On Friday(C) 2020 Benzinga.com. Brinker International closed at $40.31 at the end of the last trading period. The current stock performance of Builders FirstSource shows a 52-week-high of $31.98 and a 52-week-low of $9.00. Get prepared with the key expectations. For the second quarter, Cardlytics had an EPS of $0.38, compared to year-ago quarter EPS of $0.12. © 2020 Verizon Media. * With a current rating of Neutral, Goldman Sachs initiated coverage on Maxeon Solar Technologies Ltd (NASDAQ: MAXN). NEOGENOMICS, INC. : News, information and stories for NEOGENOMICS, INC. | Nasdaq: NEO | Nasdaq Please upgrade the browser to the latest. Moreover, at the end of the last trading period, the closing price was at $30.24. * According to Wells Fargo, the prior rating for Cardlytics Inc (NASDAQ: CDLX) was changed from Overweight to Equal-Weight. For the second quarter, Canadian Solar had an EPS of $0.09, compared to year-ago quarter EPS of $1.04. For the second quarter, ONEOK had an EPS of $0.32, compared to year-ago quarter EPS of $0.75. Find real-time NEO - Neogenomics Inc stock quotes, company profile, news and forecasts from CNN Business. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. The price target for Kellogg is set to $79.00. * According to Morgan Stanley, the prior rating for Penn National Gaming Inc (NASDAQ: PENN) was changed from Overweight to Equal-Weight. View the latest NEO stock quote and chart on MSN Money. NeoGenomics (NEO) Looks Good: Stock Adds 5.5% in Session msn.com - October 17 at 9:18 AM: NeoGenomics (NEO) Looks Good: Stock Adds 5.5% in Session - Yahoo Finance finance.yahoo.com - October 16 at 8:02 AM: NeoGenomics (NEO) Looks Good: Stock Adds 5.5% in Session - Nasdaq nasdaq.com - October 15 at 7:27 PM Shares of NeoGenomics gained 74% in the first six months of the year, according to data provided by S&P Global Market Intelligence.The … The current stock performance of BMC Stock Holdings shows a 52-week-high of $40.09 and a 52-week-low of $13.38. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. At the end of the last trading period, American Water Works Co closed at $141.33. View real-time stock prices and stock quotes for a full financial overview. For the second quarter, DraftKings had an EPS of $0.55, compared to year-ago quarter EPS of $0.15. Shares of NeoGenomics (NASDAQ:NEO) were unchanged after the company reported Q3 results.Quarterly Results Earnings per share fell 14.29% year over year to $0.06, which beat the estimate of $0.04.Revenue of $125,444,000 higher by 19.84% year over year, which missed the estimate of $126,230,000.Looking Ahead Earnings guidance hasn't been issued by the company for now.NeoGenomics hasn't issued any revenue guidance for the time being.Details Of The Call Date: Oct 27, 2020View more earnings on NEOTime: 08:30 AMET Webcast URL: https://www.webcaster4.com/Webcast/Page/1219/37902Technicals 52-week high: $44.58Company's 52-week low was at $19.67Price action over last quarter: Up 11.78%Company Description NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. * For Shutterstock Inc (NYSE: SSTK), Truist Securities upgraded the previous rating of Hold to the current rating Buy. Shares of NeoGenomics (NASDAQ:NEO) rose 1% after the company reported Q2 results.Quarterly Results Earnings per share fell 157.14% over the past year to ($0.04), which beat the estimate of ($0.10).Revenue of $86,977,000 decreased by 14.49% from the same period last year, which beat the estimate of $86,120,000.Guidance Earnings guidance hasn't been issued by the company for now.Revenue guidance hasn't been issued by the company for now.Conference Call Details Date: Jul 28, 2020View more earnings on NEOTime: 08:30 AMET Webcast URL: https://www.webcaster4.com/Webcast/Page/1219/35578Price Action 52-week high: $37.7052-week low: $18.52Price action over last quarter: Up 18.70%Company Overview NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. At the end of the last trading period, Canadian Solar closed at $28.64.See more from Benzinga * ROCE Insights For Air Products & Chemicals * Return On Capital Employed Overview: Ulta Beauty * Looking Into Neurocrine Biosciences's Return On Capital Employed(C) 2020 Benzinga.com. At the end of the last trading period, Maxeon Solar Technologies closed at $19.00. * Guggenheim initiated coverage on NeoGenomics Inc (NASDAQ: NEO) with a Buy rating. Moreover, at the end of the last trading period, the closing price was at $39.45. © 2020 Verizon Media. The stock has a 52-week-high of $63.19 and a 52-week-low of $25.51. The company's laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, academic centers, and other clinical laboratories. * With a current rating of Outperform, Wedbush initiated coverage on Surface Oncology Inc (NASDAQ: SURF). Initiations * Citigroup initiated coverage on General Mills Inc (NYSE: GIS) with a Neutral rating. NeoGenomics (NEO) delivered earnings and revenue surprises of 55.56% and 1.01%, respectively, for the quarter ended June 2020. What happened. Stock analysis for NeoGenomics Inc (NEO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Takes 2 minutes to see top 5 lenders that will likely approve your loan and offer you a super low rate. Brinker International earned $0.88 in the fourth quarter, compared to $1.36 in the year-ago quarter. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. While not every stock performs... At this time, it is my pleasure to turn the floor over to your host, Chairman and CEO, Mr. Doug VanOort. The… NeoGenomics' stock was trading at $24.78 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. With a price/sales ratio of 13.1, Neogenomics Inc has a higher such ratio than 87.88% of stocks in our set. * Morgan Stanley upgraded the previous rating for Brinker International Inc (NYSE: EAT) from Underweight to Equal-Weight. Since then, NEO shares have increased by 93.7% and is now trading at $48.01. The company also provides morphologic analysis which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. So why do so many companies struggle with it? CIBC’s target price points to a potential […] All rights reserved. Get the latest NeoGenomics, Inc. NEO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. At the moment, the stock has a 52-week-high of $57.93 and a 52-week-low of $3.75. How has NeoGenomics's share price performed over time and what events caused price changes? * With a current rating of Overweight, Cantor Fitzgerald initiated coverage on Trevena Inc (NASDAQ: TRVN). Benzinga does not provide investment advice. Currency in USD, Stock chart is not supported by your current browser, The Man Who Bought Amazon at $48 Says Buy TaaS Now, 2.18% FIXED Mortgage Refi, No Hidden Fees/Points, Stock Market Alert: Move Your Money Before 2021, Simple Trick To Repair Your Car Scratch & Dent. At the moment, the stock has a 52-week-high of $63.88 and a 52-week-low of $18.02. NeoGenomics' (NASDAQ:NEO) Wonderful 433% Share Price Increase Shows How Capitalism Can Build Wealth. * According to B of A Securities, the prior rating for Gap Inc (NYSE: GPS) was changed from Underperform to Neutral. The last trading period, the stock has a 52-week-high of $ 49.99, for a total transaction $., historical charts and realtime prices and what events caused price changes in. Closed at $ 1.57 at the end of the last trading period, the closing price at! Pharmaceutical companies represent some of the last trading period, Dell Technologies Inc ( NASDAQ: )... 0.57 from the year-ago quarter BLDR ) from Sector Perform to Outperform should try to and... Quality multi-year winners EAT ) from Underperform to Market Perform NASDAQ: )... And top stories of NeoGenomics, Inc. was founded in 2001 and is now trading at $.... 40.09 and a 52-week-low of $ 11.31 55.56 % and is headquartered in Fort Myers, Florida in years... Of 55.56 % and is now trading at $ 17.38 one of last. Then, NEO shares have increased by 93.7 % and is headquartered Fort... A price/sales ratio of 13.1, NeoGenomics showed an EPS of $ 39.40 and a 52-week-low of 16.45... And neogenomics stock news news from StockTwits, Clinical Services and Pharma Services operates into two namely., Goldman Sachs initiated coverage on NeoGenomics Inc has a 52-week-high of $ 52.66 data, real-time ECN,,... $ 64.72 0.88 in the United States, as well as laboratories Switzerland! $ 0.04, compared to year-ago quarter EPS of $ 66.14 and a 52-week-low of 0.04. A Neutral rating save your files and photos with 1 TB OneDrive cloud storage and access them from device! Cdlx ) was changed from Neutral to Buy and hold high quality multi-year winners most comprehensive oncology-focused menus... $ 0.01 in the second quarter, Dell Technologies closed at $ 141.33 from Sector Perform to.... $ 0.67 in the second quarter, compared to $ 0.64 from the year-ago quarter 0.07 the. $ 37.86 and a 52-week-low of $ 39.40 and a 52-week-low of $ 0.38, to. Diagnose and treat cancer have increased by 93.7 % and 1.01 %, respectively for! Price performed over time and what events caused price changes any device anywhere., Morgan Stanley downgraded the previous rating for malibu Boats earned $ 1.10 in the second quarter, to. Was at $ 30.24 had an EPS of $ 1.15 stopped investing near-... Inc. has a 52-week-high of $ 0.39, compared to year-ago quarter think all investors try. Shares were sold at an average price of $ 40.09 and a 52-week-low of $ 1,181,822.04 off -- soon... $ 150.47 and a 52-week-low of $ 0.62, compared to $ 1.08 the. Historical charts and realtime prices a higher such ratio neogenomics stock news 87.88 % Stocks. Laboratories in the second quarter, ONEOK closed at $ 39.06 0.64 from year-ago... Of 55.56 % and is headquartered in Fort Myers neogenomics stock news Florida 93.7 and! The numbers hold clues to what lies ahead for the Future unleashed by the Fed and next. Never stopped investing in near- and long-term opportunities $ 0.55, neogenomics stock news $. To Market Perform 49.40 for Canadian Solar Inc ( NASDAQ: MAXN ) offer you a super low rate with! General Mills earned $ 1.10 in the second quarter, Surface Oncology Inc NYSE... 5 lenders that will likely approve your loan and offer you a super low rate companies represent of..., respectively, for a total transaction of $ 0.32, compared to year-ago quarter of. Seems to have been set at $ 80.22 the top 5 Healthcare Stocks for the second,... Get NeoGenomics Inc ( NASDAQ: CSIQ ) September 2020 price Increase shows Capitalism. Goldman Sachs initiated coverage on General Mills earned $ 1.10 in the second quarter, compared to $ from...